Today, the Institute for Research in Biomedicine (IRB Barcelona) has announced the launch of the “IRB Barcelona Futur” PhD fellowship, which will allow a young student to kick start a scie
Donations give rise to a new IRB Barcelona PhD fellowship
2017 PhD4MD Programme is launched to bring research closer to clinical practice
Marco Milán: “To study how cells communicate with each other, perhaps the best model organism is the fruit fly”
IRB Barcelona and Merus form a research collaboration to develop antibodies targeting the tumor microenvironment
The Centre for Genomic Regulation (CRG), the Instituto de Investigaciones Biomédicas August Pi i Sunyer (IDIBAPS), the Institute for Research in Biomedicine (IRB Barcelona) and the Val
Marco Milán (Madrid, 1968), ICREA research professor, leads the Development and Growth C
Eduard Batlle's laboratory and Merus N.V.
Gloria Pascual, Research Associate in the Stem Cells and Cancer Laboratory at IRB Barcelona, has been invited to participate in an open debate on cancer research, organised by the TV programme 'La Sexta Noche'.
TV3 - Els Matins
Joan J. Guinovart, director of IRB Barcelona and group leader of the Metabolic Engineering and Diabetes Therapy Lab, has been on the TV programme “Els Matins de TV3”, participating in an open debate on Science vs. Humanities. Guinovart highlighted the need for a balance between these disciplines to be fully informed.
Salvador Aznar Benitah, ICREA researcher at IRB Barcelona, has been awarded the 2016 "Premi Ciutat de Barcelona" in its Life Sciences category. The Barcelona City Council acknowledges Salvador Aznar Benitah’s research published in Nature.
«Controlling a biological process from outside is the future of chemistry and opens up promising roads for advancements in pharmacological research.»
More info on this news here.
Felice Alessio Bava
former PhD student in the Translational Control of Cell Cycle and Differentiation Lab
«We suspected that CPEB1, a protein involved in regulating mRNA translation in the cytoplasm, might also be active in the nucleus and play a role in controlling pre-mRNA processing. We discovered that it affects the alternative generation in the mature mRNA of the 3'-UTR, regions where most of the elements regulating translation in time and space are located.»
More info about this news here.
«98% of the potential therapeutic molecules against diseases of the central nervous system cannot cross the blood-brain barrier. We develop peptides with the capacity to open the doors of the barrier and act as shuttles when attached to a therapeutic molecule.»
«Our study highlights the complexity of p38 functions, both in cancer and in the maintenance of normal tissues. It shows why an inhibitor of this molecule could effectively have undesirable side effects. But these do not exclude it from being a target against cancer.»
More on this news here.
Quick facts about IRB
IRB Barcelona has been awarded the "HR Excellence in Research" logo. This recognition reflects the commitment of the Institute to continuously improving its human resources policies in line with the European Charter for Researchers and the Code of Conduct for the Recruitment of Researchers. The award confirms the efforts of the Institute to ensure fair and transparent recruitment and appraisal procedures. Click here for more information.
IRB Barcelona is home to nearly 450 research, technical and support staff from 35 countries who share the common goal of contributing to the advancement of the biomedical sciences through investigator–driven research, and improving quality of life by applying advances in this field.
The convergence of biology, chemistry, and structural and computational biology is unique at IRB Barcelona and opens a strategic window to gain insight into basic molecular processes in health and disease.
Research is conducted by 23 groups organized into 5 interdisciplinary programmes. Each programme includes a diverse faculty of researchers with overlapping scientific interests. The research areas have been structured to be highly interactive, fostering multidisciplinarity by combining modern molecular biology, classical genetics, biochemistry, structural biology, bioinformatics, systems biology, advanced microscopy, and genomic and proteomic approaches.